Page 76 - Sci Tech News Today

Greenfield hockey player Matt Lavoine has a flair for the dramatic. It’s not often you get a near buzzer-beater on the ice, but the Green Wave senior captain has done so not just once, but twice in a mere 11 games so far this season. Just before the...

The COVID-19 pandemic has exposed faults in the way we assess preparedness and response capacities for public health emergencies. Existing frameworks are limited in scope, and do not sufficiently consider complex social, economic, political, regulatory, and ecological factors. One Health, through its focus on the links among humans, animals, and ecosystems, is a valuable approach through which existing assessment frameworks can be analysed and new ways forward proposed. Although in the past few ...

Editors Note: The East Carolinian does not endorse the statements made in Pirate Rants.

© Provided by Xinhua BEIJING, Jan. 17 (Xinhua) -- The Chinese Academy of Agricultural Sciences (CAAS) said it will continue to promote scientific and t

Japanese drugmaker Eisai Co. Ltd. said on Monday it had submitted a marketing authorization application in Japan for its Alzheimer’s drug lecanemab, which was recently granted accelerated approval in the United States.

Scientists who left Japan for better prospects elsewhere said the nation’s decision-makers could learn from China’s massive push to become a world leader in scientific research.

Indian doctors voice their keenness to use Iranian designed and manufactured Cancer Diagnostic Probe in 10 hospitals.

WASHINGTON--U.S. health officials on Friday approved a closely watched Alzheimer’s drug that’s been shown to modestly slow the early stages of the brain-robbing disease, albeit with potential safety risks that doctors and patients will have to carefully weigh.

LAS VEGAS--Avocados can be tricky. Their ripeness window is so narrow that a slew of memes poke fun at the fine art of deciding when to eat them.

Emergency treatment with a blood clot buster called tissue plasminogen activator for a patient who had a stroke while being treated with the experimental Alzheimer’s drug lecanemab led to a fatal cascade of brain hemorrhage and burst blood vessels, an autopsy analysis published Wednesday suggests.